Aspire Biopharma | 1.46 +0.14 +10.61% | ||
| ASBP | |||
| 高 1.49 | 开 1.35 | 量 20.71万股 | 总市值 584.00万 |
| 低 1.26 | 换 5.18% | 额 28.01万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
Aspire Biopharma(ASBP)
10小时前
$Aspire Biopharma(ASBP)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001493152-26-005640 Act: 34 Size: 578 KB 网页链接
Aspire Biopharma(ASBP)
01-31 06:19
$Aspire Biopharma(ASBP)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001493152-26-004543 Act: 34 Size: 666 KB 网页链接
Aspire Biopharma(ASBP)
01-15 19:25
$Aspire Biopharma(ASBP)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001493152-26-002326 Act: 34 Size: 600 KB 网页链接
Aspire Biopharma(ASBP)
01-14 05:35
$Aspire Biopharma(ASBP)$ 8-K Current report, item 5.02 Accession Number: 0001493152-26-002057 Act: 34 Size: 252 KB 网页链接
Aspire Biopharma(ASBP)
01-06 21:45
$Aspire Biopharma(ASBP)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001493152-26-000518 Act: 34 Size: 447 KB 网页链接
Aspire Biopharma(ASBP)
2025-12-15 19:25
$Aspire Biopharma(ASBP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003714 Act: 33 Size: 1 KB 网页链接
Aspire Biopharma(ASBP)
2025-12-03 19:05
$Aspire Biopharma(ASBP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-25-025819 Act: 33 Size: 9 MB 网页链接
Aspire Biopharma(ASBP)
2025-11-15 06:05
$Aspire Biopharma(ASBP)$ 10-Q/A [Amend] Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-25-023619 Act: 34 Size: 6 MB 网页链接
Aspire Biopharma(ASBP)
2025-11-14 21:25
$Aspire Biopharma(ASBP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-25-022595 Act: 34 Size: 6 MB 网页链接
Aspire Biopharma(ASBP)
2025-11-14 21:05
$Aspire Biopharma(ASBP)$ 8-K Current report, items 1.01, 1.02, 2.03, 3.02, and 9.01 Accession Number: 0001493152-25-022580 Act: 34 Size: 643 KB 网页链接
Aspire Biopharma(ASBP)
2025-11-06 05:55
$Aspire Biopharma(ASBP)$ 8-K Current report, item 5.07 Accession Number: 0001493152-25-020891 Act: 34 Size: 264 KB 网页链接
Aspire Biopharma(ASBP)
2025-10-18 05:25
$Aspire Biopharma(ASBP)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001493152-25-018512 Act: 34 Size: 258 KB 网页链接
Aspire Biopharma(ASBP)
2025-09-30 18:15
$Aspire Biopharma(ASBP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003148 Act: 33 Size: 1 KB 网页链接
Aspire Biopharma(ASBP)
2025-09-27 05:15
$Aspire Biopharma(ASBP)$ 8-K Current report, items 3.02, 4.01, and 9.01 Accession Number: 0001493152-25-015773 Act: 34 Size: 264 KB 网页链接
Aspire Biopharma(ASBP)
2025-09-27 05:15
$Aspire Biopharma(ASBP)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-25-015778 Act: 33 Size: 11 MB 网页链接
Aspire Biopharma(ASBP)
2025-09-23 18:05
$Aspire Biopharma(ASBP)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-25-014523 Act: 34 Size: 216 KB 网页链接
Aspire Biopharma(ASBP)
2025-09-19 05:05
$Aspire Biopharma(ASBP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-25-014085 Act: 33 Size: 11 MB 网页链接
Aspire Biopharma(ASBP)
2025-09-09 05:15
$Aspire Biopharma(ASBP)$ PRE 14A Other preliminary proxy statements Accession Number: 0001641172-25-026871 Act: 34 Size: 219 KB 网页链接
Aspire Biopharma(ASBP)
2025-08-23 05:25
$Aspire Biopharma(ASBP)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001641172-25-025257 Act: 34 Size: 887 KB 网页链接
Aspire Biopharma(ASBP)
2025-08-14 05:05
$Aspire Biopharma(ASBP)$ 10-Q/A [Amend] Quarterly report [Sections 13 or 15(d)] Accession Number: 0001641172-25-023566 Act: 34 Size: 4 MB 网页链接